David Arkowitz Yumanity Therapeutics, Inc. (YMTX) insider trading activity

David Arkowitz is of YUMANITY THERAPEUTICS, INC.. Currently has a direct ownership of 0 shares of YMTX, which is worth approximately $0. The most recent transaction as insider was on Jun 30, 2025, when has been sold 16,571 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0

100.0% 3M change

100.0% 12M change

Total Value Held $0

David Arkowitz Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jun 30 2025	SELL Sale (or disposition) back to the issuer	-	16,571 Reduced 100.0%	0 Common Stock
Jun 25 2025	BUY Grant, award, or other acquisition	-	6,000 Added 24.85%	18,141 Common Stock
Jun 23 2025	SELL Payment of exercise price or tax liability	$1,223 $0.26 p/Share	4,706 Reduced 27.93%	12,141 Common Stock
Jun 23 2025	BUY Exercise of conversion of derivative security	$7,625 $0.61 p/Share	12,500 Added 42.59%	16,847 Common Stock
Dec 22 2020	BUY Grant, award, or other acquisition	$99,981 $23.0 p/Share	4,347 Added 50.0%	4,347 Common Stock

Also insider at

FSTX

F-star Therapeutics, Inc. Healthcare

Director

FLXN

Flexion Therapeutics Inc

Chief Financial Officer

MCRB

Seres Therapeutics, Inc. Healthcare

Chief Financial Officer

IBIO

iBio, Inc. Healthcare

Director

David Arkowitz

Cambridge, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells YMTX shares.

Notify only if

Value

Insider Trading

Get notified when an Yumanity Therapeutics, Inc. insider buys or sells YMTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to YUMANITY THERAPEUTICS, INC.

Track Activities on YMTX

Account